HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Oxalic Acid → 1-(3,5-Di-O-benzoyi-beta-L-arabinofuranosyl)uracil

HRID 496573
Notes
Print preview

Reaction equation

HRID 496573 reaction equation
[C:1]([O:9][C@@H:10]1[C@H:14]([CH2:15][O:16][C:17](=[O:24])[C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[O:13][C@H:12]([N:25]2[CH:32]=[CH:31][C:29](=[O:30])[NH:28][C:26]2=[O:27])[C@H:11]1[OH:33])(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1(N=C=NC2CCCCC2)CCCCC1.ClC(Cl)C(O)=O.C(O)(=O)C(O)=O.[BH4-].[Na+]>C(OCC)(=O)C.CO.N1C=CC=CC=1.C1C=CC=CC=1.CS(C)=O>[C:1]([O:9][C@H:10]1[C@H:14]([CH2:15][O:16][C:17](=[O:24])[C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[O:13][C@H:12]([N:25]2[CH:32]=[CH:31][C:29](=[O:30])[NH:28][C:26]2=[O:27])[C@@H:11]1[OH:33])(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

10

Reactant 5

HCID 971Oxalic AcidHCID 6597Dichloroacetic AcidHCID 10868DicyclohexylcarbodiimideHCID 4311764Sodium borohydrideHCID 667170671-(3,5-Di-O-benzoyi-beta-L-xylofuranosyl)uracil

Product 1

HCID 667171061-(3,5-Di-O-benzoyi-beta-L-arabinofuranosyl)uracil
Yield 66.2%

Reagents, catalysts & solvents 4

HCID 887MethanolSolventHCID 1049PyridineSolventHCID 8857Ethyl AcetateSolvent2×HCID 18518713Benzene dimethylsulfoxideSolvent

Procedure

To a solution of 1-(3,5-di-O-benzoyl-β-L-xylofuranosyl)uracil 11 (8 g, 17.7 mL) in an anhydrous benzene-DMSO mixture (265 mL, 6:4, v/v) were added anhydrous pyridine (1.4 mL), dicyclohexylcarbodiimide (10.9 g, 53 mmol) and dichloroacetic acid (0.75 mL). The resulting mixture was stirred at room temperature for 4 h, then diluted with ethyl acetate (400 mL) and a solution of oxalic acid (4.8 g, 53 mmol) in methanol (14 mL) was added. After being stirred for 1 h, the solution was filtered. The filtrate was washed with a saturated NaCl solution (2×500 mL), 3% NaHCO3 solution (2×500 mL) and water (2×500 mL). The organic phase was dried over Na2SO4, then evaporated under reduced pressure. The resulting residue was then solubilized in an EtOH absolute-benzene mixture (140 mL, 2:1, v/v). To this solution at 0° C. was added NaBH4 (0.96 g, 26.5 mmol). After being stirred for 1 h, the solution was diluted with ethyl acetate (400 mL), then filtered. The filtrate was washed with a saturated NaCl solution (400 mL) and water (400 mL). The organic phase was dried over Na2SO4, then evaporated under reduced pressure. The resulting crude material was purified by silica gel column chromatography [eluent: stepwise gradient of methanol (0-3%) in dichloromethane to give 12 (5.3 g, 66%) which was crystallized from acetontrile: mp=182-183° C.; 1H-NMR (DMSO-d6): δ11.35 (br s, 1H, NH), 8.0-7.5 (m, 11H, 2 C6H5CO, H-6), 6.23 (br s, 1H, OH-2′), 6.15 (d, 1H, H-1′, J1′-2′=4 Hz), 5.54 (d, 1H, H-5, J5-6=8.1 Hz), 5.37 (t, 1H, H-3′, J3′-2′=J3′-4′=2.6 Hz), 4.7-4.6 (m, 2H, H-5′ and H-5″), 4.5 (m, 1H, H-4′), 4.4 (m, 1H, H-2′); MS: FAB>0 (matrix GT) m/z 453 (M+H)+, 341 (S)+, 113 (BH2)+, 105 (C6H5CO)+; FAB<0 (matrix GT) m/z 451 (M−H)−, 121 (C6H5CO2)−, 111 (B)−; Anal. Calcd for C23H20N2O8: C, 61.06; H, 4.46; N, 6.19. Found: C, 60.83; H, 4.34; N, 6.25.

Workup

  1. stirringAfter being stirred for 1 h
  2. filtrationthe solution was filtered
  3. washThe filtrate was washed with a saturated NaCl solution (2×500 mL), 3% NaHCO3 solution (2×500 mL) and water (2×500 mL)
  4. dry with materialThe organic phase was dried over Na2SO4
  5. customevaporated under reduced pressure
  6. stirringAfter being stirred for 1 h
  7. filtrationfiltered
  8. washThe filtrate was washed with a saturated NaCl solution (400 mL) and water (400 mL)
  9. dry with materialThe organic phase was dried over Na2SO4
  10. customevaporated under reduced pressure
  11. customThe resulting crude material was purified by silica gel column chromatography [eluent

Sources & evidence

ORD record
ord-4b7b2c1138a644899ab4fe3240b51ecb
Source dataset
uspto-grants-2005_09
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US06946450B2

Reaction notes

Loading…

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes